Coverage dated July 30, 2023 to July 31, 2023

Suffering from long COVID? NIH launches clinical trials for treatments

Headline from NBC 6 South Florida

The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions.

NBC 6 South Florida's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

9 articles, oldest first.

  1. CBS News

    First long COVID treatment clinical trials from NIH getting underway (opens CBS News)

    Published

    CBS News's feed description

    Researchers will test a range of potential treatments, from melatonin to Paxlovid, to see if they relieve symptoms of long COVID.

  2. UPI

    NIH announces start of Phase 2 clinical trials for 4 long COVID treatments (opens UPI)

    Published

    UPI's feed description

    Federal health officials on Monday kicked off enrollment for at least four potential treatments for long COVID and said additional trials for at least seven more treatments are coming soon.

  3. Forbes

    NIH Opens Clinical Trials For Long Covid Treatment (opens Forbes)

    Published

    Forbes's feed description

    The trials are part of the world’s largest effort to understand, treat and prevent long Covid.

  4. NBC 6 South Florida

    Suffering from long COVID? NIH launches clinical trials for treatments (opens NBC 6 South Florida)

    Published

    NBC 6 South Florida's feed description

    The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions.

  5. The Boston Globe

    NIH announces long-COVID treatment studies with hundreds of patients (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    The areas to be studied include measures to reduce viral persistence and another to alleviate brain fog, memory loss, and other cognitive problems.

  6. Nature

    NIH launches trials for long-COVID treatments: what scientists think (opens Nature)

    Published

    Nature's feed description

    World’s largest study of long COVID will evaluate potential therapies for brain fog, sleep disruption and more.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Suffering from long COVID? NIH launches clinical trials for treatments | Since Then